Lannett (LCI) – Lawsuits Will Wipe Out The Equity" Citron Research – ValueWalk Premium
Lannett

Lannett (LCI) – Lawsuits Will Wipe Out The Equity" Citron Research

Lannett will be the First Pharma Company to go Bankrupt amid Continuing Drug Pricing Scrutiny

If Even Modest Price Cuts Hit Either of Lannett’s Cash Cow Drugs, It Will Violate Its Debt Covenants 

$13-$15 Near Term Target

Equity Worthless Over Long-Term

Over the past year, almost every media outlet in the US has dissected the pharmaceutical industry to expose the culprits of rampant opportunistically driven price gouging. We are . . .

SORRY!

This content is exclusively for paying members.

If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.


X
Saved Articles
X
TextTExtLInkTextTExtLInk

The top investors are reading ValuewalkPremium.

Click here to learn why

0